| Small-Caps Continue to Outperform in Final Week of February |
| |
|
In a surprise move, both small- and mid-cap indices outperformed large caps in the last week of February, which could also suggest that trend might be shifting towards non-index names.
The S&P BSE Small-cap index rose 3.4% last week while large cap indexes rose less than 1%.
More than 100 stocks in the S&P BSE Small-cap index rallied between 10%-40% last week alone.
|
|
| |
|
| FDA to Host Public Meeting in April to Discuss Regulation of CBD |
| |
|
The FDA is holding a public meeting in April to discuss regulation of cannabidiol (CBD) products, according to testimony from FDA Commissioner Gottlieb during a House hearing last week.
The meeting is expected to explore new pathways for hemp-derived CBD products to be sold legally in the food and supplement markets, while protecting research into future pharma applications.
A favorable outcome from the meeting should further boost prospects for CBD companies like Level Brands (NYSE American: LEVB) and GSRX Industries (OTCQB: GSRX).
|
|
| |
|
| GSRX Industries (OTCQB: GSRX) Raises Q1 Guidance to $2.7M-$2.9M |
| |
|
GSRX Industries (OTCQB: GSRX) raised its first quarter guidance last week based on stronger than projected sales at the company’s six owned-and-operated dispensaries in Puerto Rico and California. Additional growth is being fueled by robust sales of the company’s recently launched Pure and Natural CBD products.
Key Quote: “We continue to see strong demand across all our U.S. operations and look forward to reporting record sales for the quarter.” – Les Ball, CEO
What’s Next: GSRX has several more dispensaries slated to open in the near term in Puerto Rico and has announced the opening of its first retail CBD kiosk with two additional locations under construction. Learn more by watching our exclusive webinar with GSRX Chairman Christian Briggs: https://www.redchip.com/events/38/gsrx-industries-webinar/gsrx.
Disclosure
GSRX Industries (OTCQB: GSRX) is a client of RedChip Companies. RedChip Companies, Inc. received 1,000,000 registered shares of GSRX for consulting services. Be advised RedChip intends to sell some or all of its shares at any time, including when you are buying.
|
|
| |
|
| Cemtrex (NASDAQ: CETX) Announces H Mart as Latest SmartDesk Client |
| |
|
Cemtrex Inc. (NASDAQ: CETX), a leading global technology and company, announced that leading specialty grocer H Mart is Cemtrex’s latest SmartDesk Enterprise Client to evaluate the product for use on its corporate campus.
H Mart is a billion-dollar grocery store chain that specializes in Asian foods, over 80 locations across the world. The SmartDesk will be utilized in their corporate offices as a cutting-edge and efficient solution for their busy workflows.
Key Quote: “We are excited to explore the use cases for the SmartDesk at H Mart,” said Saagar Govil, CEO and Chairman of Cemtrex.
The Backstory: Cemtrex, Inc. is the manufacturer of the SmartDesk, the world’s most advanced workstation. Cemtrex is a diversified technology company that's driving innovation in a wide range of sectors, including smart technology, virtual and augmented realities, advanced electronic systems, industrial solutions, and intelligent security systems.
Disclosure
Cemtrex, Inc. (NASDAQ: CETX) agreed to pay RedChip Companies, Inc. a monthly cash fee for three (3) months of investor relation awareness services.
|
|
| |
|
| Final Challenge of Taser (NASDAQ: AAXN) to Validity of Digital’s (NASDAQ: DGLY) Auto-Activation ’452 Patent Rejected by Patent Office |
| |
|
Digital Ally, Inc. (NASDAQ: DGLY), which develops, manufactures, and markets advanced video surveillance products for law enforcement, homeland security, and commercial applications, is pleased to announce yet another major victory in its legal battles against Axon Enterprise, Inc. (NASDAQ: AAXN; formerly known as Taswer). On February 25, 2019, the Patent Office again rejected Taser’s attempts to invalidate Digital Ally’s Patent No. 9,253,452 (“the ’452 Patent”).
The Pretrial Order further notes that Digital Ally is seeking reasonable royalty damages as a result of TASER’s infringement of the ’452 Patent from February 2, 2016 through August 17, 2018 of $68,456,524 and that prior to trial in this matter, Digital Ally will supplement its damages calculations.
Key Quote: “This decision represents another confirmation of the validity of our auto-activation patents. To date, every court and every judge that has examined the validity of these auto-activation patents has confirmed their strength and found them valid.” Digital Ally’s CEO, Stanton Ross
The Backstory: Digital Ally, headquartered in Lenexa, KS, specializes in the design and manufacture of the highest quality video recording equipment and video analytic software. Digital Ally pushes the boundaries of technology in industries such as law enforcement, emergency management, commercial fleets, and consumer use. Digital Ally’s complete product solutions include in-car and body cameras, cloud and local management software, and automatic recording technology. These products work seamlessly together and are simple to install and operate. Digital Ally products are sold by domestic direct sales representatives and international distributors worldwide.
For additional news and information please visit www.digitalallyinc.com or follow DGLY on Twitter @digitalallyinc and Facebook www.facebook.com/DigitalAllyInc.
Disclosure
Digital Ally, Inc. (NASDAQ: DGLY) is a client of RedChip Companies, Inc. DGLY agreed to pay RedChip Companies, Inc., a monthly cash fee for four (4) months of RedChip investor awareness services.
|
|
| |
|
| Interpace Diagnostics (NASDAQ: IDXG) Announces Preliminary 2018 Revenues, Annual Net Increased 38% YoY to $21.9 Million |
| |
|
Annual Net Revenues for 2018 are expected to be at the high end of the guidance previously given amounting to 38% growth over 2017 or approximately $21.9 million vs. $15.9 million.
Key Quote: “We are extremely pleased with our performance and preliminary net revenues for 2018 and we would like to thank our dedicated employees for consistently performing.” Company’s President and Chief Executive Officer, Jack Stover
The Company plans to host a conference call on Tuesday, March 19, 2019 at 4:30 p.m. ET to review the Company's 2018 Fourth Quarter and Full Year results.
Purpose: Interpace Diagnostics Announces Fourth Quarter 2018 Financial Results
Date and Time: Tuesday, March 19, 2018 at 4:30 p.m. ET
Dial-in Number (Domestic): (877) 407 - 0312
Dial-in Number (International): +1 (201) 389 - 0899
Confirmation Number: 136 88 229
Webcast Access: https://webcasts.eqs.com/interpacedia20190319
The Backstory: Interpace (NASDAQ: IDXG) is a fully integrated commercial and bioinformatics company that provides clinically useful molecular diagnostic tests and pathology services for evaluating risk of cancer by leveraging the latest technology in personalized medicine for improved patient diagnosis and management. The Company currently has four commercialized molecular tests and one test in a clinical evaluation process (CEP); PancraGEN® for the diagnosis and prognosis of pancreatic cancer from pancreatic cysts; ThyGeNEXT™ for the diagnosis of thyroid cancer from thyroid nodules utilizing a next generation sequencing assay; ThyraMIR® for the diagnosis of thyroid cancer from thyroid nodules utilizing a proprietary gene expression assay; and RespriDX™ that differentiates lung cancer of primary vs. metastatic origin.
|
|
| |
|
| |
| Quote of the Week |
| |
"Get to know management, look for intelligence, a high level of integrity, strong communication skills and make sure they understand their products and business well."
- Byron Roth CEO of ROTH Capital Partners |
|
|
|
|
|
|
|
| About RedChip |
| |
| RedChip Companies, an Inc. 5000 company, is an international investor relations, media, and research firm focused on small-cap and mid-cap companies. Since 1992, RedChip has delivered concrete, measurable results for its clients through the most comprehensive service platform in the industry for small-cap and mid-cap companies. These services include a worldwide distribution network for its stock research written by analysts holding the CFA designation; retail and institutional roadshows in major U.S. cities; outbound marketing to stock brokers, RIAs, institutions, and family offices; a digital media investor relations platform that has generated over 2.3 million unique investor views; quarterly global online institutional and retail investor conferences that reach over 10,000 investors annually; "The RedChip Money Report" television show which airs in 100 million homes across the U.S. on The Family Channel; a weekly newsletter delivered to 60,000 investors; TV commercials in local and national markets; corporate and product videos; website design; and traditional investor relation services, which include press release writing, development of investor presentations, quarterly conference call script writing, strategic consulting, capital raising, and more. |
| |
| RedChip Disclosure |
| |
RedChip Companies, Inc. research reports, company profiles and other investor relations materials, publications or presentations, including web content, are based on data obtained from sources we believe to be reliable but are not guaranteed as to accuracy and are not purported to be complete. As such, the information should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed in RedChip reports, company profiles, or other investor relations materials and presentations are subject to change. RedChip Companies and its affiliates may buy and sell shares of securities or options of the issuers mentioned on this website at any time.
RedChip Visibility is a division of RedChip Companies, Inc. and offers research services to paying clients. In the purview of Section 17(b) of the Securities Act of 1933 and in the interest of full disclosure, we call the reader's attention to the fact that the RedChip Companies Inc. is an investor relations firm hired by certain Companies to increase investor awareness to the small-cap equity community.
Stock market investing is inherently risky. RedChip Companies is not responsible for any gains or losses that result from the opinions expressed on this website, in its research reports, company profiles or in other investor relations materials or presentations that it publishes electronically or in print.
We strongly encourage all investors to conduct their own research before making any investment decision. For more information on stock market investing, visit the Securities and Exchange Commission ("SEC") at www.sec.gov and view RedChip’s Disclosures. |
|
| |
|
|
| |
|
Copyright © 2019 RedChip Companies, Inc. All Rights Reserved.
You are receiving this message because this email address has signed up to receive News Alerts.
If you received this email by mistake you can unsubscribe from all emails.
|
|
|
|
